4.7 Article

CombiROC: an interactive web tool for selecting accurate marker combinations of omics data

Journal

SCIENTIFIC REPORTS
Volume 7, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/srep45477

Keywords

-

Ask authors/readers for more resources

Diagnostic accuracy can be improved considerably by combining multiple markers, whose performance in identifying diseased subjects is usually assessed via receiver operating characteristic (ROC) curves. The selection of multimarker signatures is a complicated process that requires integration of data signatures with sophisticated statistical methods. We developed a user-friendly tool, called CombiROC, to help researchers accurately determine optimal markers combinations from diverse omics methods. With CombiROC data from different domains, such as proteomics and transcriptomics, can be analyzed using sensitivity/specificity filters: the number of candidate marker panels rising from combinatorial analysis is easily optimized bypassing limitations imposed by the nature of different experimental approaches. Leaving to the user full control on initial selection stringency, CombiROC computes sensitivity and specificity for all markers combinations, performances of best combinations and ROC curves for automatic comparisons, all visualized in a graphic interface. CombiROC was designed without hard-coded thresholds, allowing a custom fit to each specific data: this dramatically reduces the computational burden and lowers the false negative rates given by fixed thresholds. The application was validated with published data, confirming the marker combination already originally described or even finding new ones. CombiROC is a novel tool for the scientific community freely available at http://CombiROC.eu.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

The evolutionary history of the polyQ tract in huntingtin sheds light on its functional pro-neural activities

Raffaele Iennaco, Giulio Formenti, Camilla Trovesi, Riccardo Lorenzo Rossi, Chiara Zuccato, Tiziana Lischetti, Vittoria Dickinson Bocchi, Andrea Scolz, Cristina Martinez-Labarga, Olga Rickards, Michela Pacifico, Angelica Crottini, Anders Pape Moller, Richard Zhenghuan Chen, Thomas Francis Vogt, Giulio Pavesi, David Stephen Horner, Nicola Saino, Elena Cattaneo

Summary: This study investigated the function and evolution of the CAG repeat sequence in the Huntingtin gene. It found that the CAG-encoded polyQ sequence is under natural selection and small variations in its length can influence neuronal function. These findings highlight the importance of CAG repeat sequences in evolutionary adaptation.

CELL DEATH AND DIFFERENTIATION (2022)

Article Multidisciplinary Sciences

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Elisabetta Cameroni, John E. Bowen, Laura E. Rosen, Christian Saliba, Samantha K. Zepeda, Katja Culap, Dora Pinto, Laura A. VanBlargan, Anna De Marco, Julia di Iulio, Fabrizia Zatta, Hannah Kaiser, Julia Noack, Nisar Farhat, Nadine Czudnochowski, Colin Havenar-Daughton, Kaitlin R. Sprouse, Josh R. Dillen, Abigail E. Powell, Alex Chen, Cyrus Maher, Li Yin, David Sun, Leah Soriaga, Jessica Bassi, Chiara Silacci-Fregni, Claes Gustafsson, Nicholas M. Franko, Jenni Logue, Najeeha Talat Iqbal, Ignacio Mazzitelli, Jorge Geffner, Renata Grifantini, Helen Chu, Andrea Gori, Agostino Riva, Olivier Giannini, Alessandro Ceschi, Paolo Ferrari, Pietro E. Cippa, Alessandra Franzetti-Pellanda, Christian Garzoni, Peter J. Halfmann, Yoshihiro Kawaoka, Christy Hebner, Lisa A. Purcell, Luca Piccoli, Matteo Samuele Pizzuto, Alexandra C. Walls, Michael S. Diamond, Amalio Telenti, Herbert W. Virgin, Antonio Lanzavecchia, Gyorgy Snell, David Veesler, Davide Corti

Summary: The Omicron variant of SARS-CoV-2 has raised concerns due to its 37 amino acid substitutions in the spike protein, particularly in the receptor-binding domain (RBD), leading to increased binding affinity with human ACE2. Neutralizing activity against Omicron was greatly reduced in convalescent and vaccinated individuals compared to the ancestral virus, but this decrease was less significant after a third vaccine dose. Broadly neutralizing monoclonal antibodies recognizing conserved RBD epitopes may be crucial in combating the Omicron variant and future zoonotic transmissions.

NATURE (2022)

Article Genetics & Heredity

LINE1 are spliced in non-canonical transcript variants to regulate T cell quiescence and exhaustion

Federica Marasca, Shruti Sinha, Rebecca Vadala, Benedetto Polimeni, Valeria Ranzani, Elvezia Maria Paraboschi, Filippo Vittorio Burattin, Marco Ghilotti, Mariacristina Crosti, Maria Luce Negri, Susanna Campagnoli, Samuele Notarbartolo, Andrea Sartore-Bianchi, Salvatore Siena, Daniele Prati, Giovanni Montini, Giuseppe Viale, Olga Torre, Sergio Harari, Renata Grifantini, Giulia Solda, Stefano Biffo, Sergio Abrignani, Beatrice Bodega

Summary: This study reveals how non-canonical splicing variant LINE1 maintains T cell quiescence and interferes with gene expression, thus affecting cell function.

NATURE GENETICS (2022)

Article Immunology

Clonal structure, stability and dynamics of human memory B cells and circulating plasmablasts

Ganesh E. Phad, Dora Pinto, Mathilde Foglierini, Murodzhon Akhmedov, Riccardo L. Rossi, Emilia Malvicini, Antonino Cassotta, Chiara Silacci Fregni, Ludovica Bruno, Federica Sallusto, Antonio Lanzavecchia

Summary: This study provides a systematic description of the structure, stability, and dynamics of the human memory B cell pool, and suggests that memory B cells play a crucial role in the generation of plasma cells.

NATURE IMMUNOLOGY (2022)

Review Immunology

Human T lymphocytes at tumor sites

Samuele Notarbartolo, Sergio Abrignani

Summary: CD4(+) and CD8(+) T-RM cells play a crucial role in the adaptive immune response against tumors. However, tumors can evade the surveillance of T-RM cells, leading to clinical manifestation. The generation and maintenance of T-RM cells, as well as their role in antitumor immunity and immunotherapy, are still areas of ongoing research.

SEMINARS IN IMMUNOPATHOLOGY (2022)

Article Medicine, General & Internal

Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2

Annarita Miluzio, Alessandro Cuomo, Chiara Cordiglieri, Lorena Donnici, Elisa Pesce, Mauro Bombaci, Matteo Conti, Alessandra Fasciani, Luigi Terracciano, Lara Manganaro, Mirco Toccafondi, Alessandra Scagliola, Stefania Oliveto, Sara Ricciardi, Renata Grifantini, Raffaele De Francesco, Sergio Abrignani, Nicola Manfrini, Stefano Biffo

Summary: The study found that the binding of the SARS-CoV-2 virus to hACE2 receptors is the first step in infection, but the abundance of receptors is influenced by various factors. Further research revealed SLC1A5 as a factor involved in receptor localization and viral entry, and co-expression with hACE2 improved the prediction of SARS-CoV-2 binding and entry. The Omicron variant showed higher efficiency in binding to hACE2 sites, but was equally sensitive to SLC1A5 downregulation.

EBIOMEDICINE (2023)

Article Biochemistry & Molecular Biology

Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation

Lisa Pagani, Clizia Chinello, Giulia Risca, Giulia Capitoli, Lucrezia Criscuolo, Andrea Lombardi, Riccardo Ungaro, Davide Mangioni, Isabella Piga, Antonio Muscatello, Francesco Blasi, Andrea Favalli, Martina Martinovic, Andrea Gori, Alessandra Bandera, Renata Grifantini, Fulvio Magni

Summary: By studying the plasma proteome of 43 COVID-19 patients, differentially expressed proteins related to the severity of infection were identified. Three proteins were found to be able to accurately distinguish different stages of infection. These proteins may be associated with the severity of the disease and the immune response.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Pharmacology & Pharmacy

Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease

Giulia Birolini, Marta Valenza, Ilaria Ottonelli, Francesca Talpo, Lucia Minoli, Andrea Cappelleri, Mauro Bombaci, Claudio Caccia, Caterina Canevari, Arianna Trucco, Valerio Leoni, Alice Passoni, Monica Favagrossa, Maria Rosaria Nucera, Laura Colombo, Saverio Paltrinieri, Renzo Bagnati, Jason Thomas Duskey, Riccardo Caraffi, Maria Angela Vandelli, Franco Taroni, Mario Salmona, Eugenio Scanziani, Gerardo Biella, Barbara Ruozi, Giovanni Tosi, Elena Cattaneo

Summary: The study demonstrates that delivering cholesterol to the brain using nanoparticles can effectively reverse cognitive decline and neuropathological signs in Huntington's disease (HD). The administration of hybrid-g7-NPs-chol in both early and late stages of HD shows long-term therapeutic effects without adverse reactions. The findings highlight the therapeutic potential of cholesterol-based strategies in HD patients.

PHARMACOLOGICAL RESEARCH (2023)

Article Immunology

TMEM123 a key player in immune surveillance of colorectal cancer

Elisa Pesce, Chiara Cordiglieri, Mauro Bombaci, Serenella Eppenberger-Castori, Stefania Oliveto, Cristina Manara, Mariacristina Crosti, Caner Ercan, Mairene Coto, Andrea Gobbini, Susanna Campagnoli, Tiziano Donnarumma, Manuele Martinelli, Valeria Bevilacqua, Elisa De Camilli, Paola Gruarin, Maria L. Sarnicola, Elisa Cassinotti, Ludovica Baldari, Giuseppe Viale, Stefano Biffo, Sergio Abrignani, Luigi M. Terracciano, Renata Grifantini

Summary: Colorectal cancer (CRC) is a major cause of cancer-related death. The interplay between effector immune cells and cancer cells in the tumor site plays a key role in determining tumor elimination or outgrowth. TMEM123 protein is over-expressed in infiltrating CD4 and CD8 T lymphocytes and contributes to their effector phenotype. TMEM123 plays a role in lymphocyte migration and cytoskeleton organization, and its presence is associated with improved survival in CRC patients.

FRONTIERS IN IMMUNOLOGY (2023)

Article Immunology

SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotype

Ylenia Silvestri, Francesca Clemente, Giorgia Moschetti, Sara Maioli, Elena Carelli, Alejandro Espadas de Arias, Rosanna Torelli, Elena Longhi, Tullia De Feo, MariaCristina Crosti, Maria Lucia Sarnicola, Mario Salvi, Giovanna Mantovani, Maura Arosio, Mauro Bombaci, Elisa Pesce, Renata Grifantini, Sergio Abrignani, Jens Geginat, Ilaria Muller

Summary: SARS-CoV-2 infection can lead to thyroid disorders like subacute thyroiditis (SAT). This study aimed to investigate the role of T-cells in SAT following severe COVID disease (COV-A-SAT). T-cells from COV-A-SAT patients were analyzed and compared to controls. The results showed that COV-A-SAT was associated with specific HLA haplotypes and activated T-cell responses. Tissue-resident memory cells were present in the thyroid, suggesting a prolonged immune response in the target tissue.

CLINICAL IMMUNOLOGY (2023)

Correction Immunology

TMEM123 a key player in immune surveillance of colorectal cancer (vol 14, 1194087, 2023)

Elisa Pesce, Chiara Cordiglieri, Mauro Bombaci, Serenella Eppenberger-Castori, Stefania Oliveto, Cristina Manara, Mariacristina Crosti, Caner Ercan, Mairene Coto, Andrea Gobbini, Susanna Campagnoli, Tiziano Donnarumma, Manuele Martinelli, Valeria Bevilacqua, Elisa De Camilli, Paola Gruarin, Maria L. Sarnicola, Elisa Cassinotti, Ludovica Baldari, Giuseppe Viale, Stefano Biffo, Sergio Abrignani, Luigi M. Terracciano, Renata Grifantini

FRONTIERS IN IMMUNOLOGY (2023)

Article Health Care Sciences & Services

Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study

Andrea Lombardi, Giacomo M. Butta, Lorena Donnici, Giorgio Bozzi, Massimo Oggioni, Patrizia Bono, Malvina Matera, Dario Consonni, Serena Ludovisi, Antonio Muscatello, Ferruccio Ceriotti, Matteo Conti, Susanna Scaglioni, Greta Gallo, Edoardo Scarpa, Michael Letko, Sergio Abrignani, Renata Grifantini, Raffaele De Francesco, Andrea Gori, Lara Manganaro, Alessandra Bandera

Summary: This study assessed the immunogenicity of the mRNA-1273 vaccine in people living with HIV (PLWHIV). The results showed that in PLWHIV with well-controlled ART, viral suppression, and CD4+ T cell count, inoculation with the mRNA-1273 vaccine produced detectable antibody response, similar to individuals without HIV infection.

LANCET REGIONAL HEALTH-EUROPE (2022)

No Data Available